Pharmaceutical Tech

Mar312016 by Pharmaceutical TechNo Comments

Collaborations are a Secret Boon for the Pharma Industry in India

After it was recently announced that Bristol-Meyes Squibb and Astra Zenca ended their partnership and Aurobindo Pharma would acquire Dublin-based Actavis, the question on everyone’s minds seems to be, what next? The pharma industry has seen a double-growth in recent times owing to breakthrough patents in the field of cancer drugs and research. Therapies which are closely linked to winter related ailments, have posted strong double digit growths (such as respiratory at over 18.7 per cent, pain or analgesics at over 10.1 per cent), resulting in acute therapies growing faster than chronic segment, for the second consecutive month. For the full year 2013, the pharmaceutical market was reported at Rs 78,644 crore, with a growth of 9.9 per cent, over the same period last year. The Indian mark...

Mar302016 by Pharmaceutical TechNo Comments

Is South Africa Trying to delay Patents on New Medicines?

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Distribution and Logistics, Pharmaceutical Patenting

In a recent report by the Guardian, it was revealed that leaked documents showed lobbying proposals to delay laws that would allow fast introduction of generic medicines in South Africa. Shockingly, this means patents on breakthrough (read recently discovered medicine) drugs could be halted, but for what? If the changes to the new intellectual property law take place, this could be a definite reality, warns the Guardian. Drug companies in South Africa have been accused of planning a covert, well-funded campaign to delay the introduction of laws that threaten their profits. Leaked documents show that pharmaceutical companies planned a $450,000 campaign, involving a high-profile consultancy based in Washington, DC, against changes to intellectual property laws that would enable their pat...

Mar272016 by Pharmaceutical TechNo Comments

Glenmark Gives India the Push by Topping its Anti-Diabetes Drug

Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Collaboration

Whatever Glenmark wanted to prove by introducing Zitamed and ZIta, their new anti-diabetes drugs, they’ve definitely topped this season. Mumbai-based Glenmark Pharmaceuticals introduced the two anti-diabetes drugs in aRs 3,000-crore lucrative anti-diabetes market dominated by multinationals The drugmaker, which is locked in a bitter patent infringement battle with US drug firm Merck Sharp and Dohme's (MSD) over these drugs, has managed to rake in Rs 16 crore in just eight months since it launched them, according to data available with All India Organisation of Chemists and Association (AIOCD). In a sort of kickback, Glenmark has priced these drugs at a third of the price of its competitors. Win? We definitely think so. This move may not only rattle the existing market, but also multina...

Mar252016 by Pharmaceutical TechNo Comments

How Anti-Depressants Work to Help you Feel Better

Cure & Prevention, Specific Drugs

Depression is essentially a strange state of mental breakdown, gradual or rapid. Depression strikes some 35 million people worldwide, according to the World Health Organization, contributing to lowered quality of life as well as an increased risk of heart disease and suicide. Treatments typically include psychotherapy, support groups and education as well as psychiatric medications. The action of these compounds is fairly common. Certain anti-depressants increase available levels of serotonin, sometimes referred to as the feel-good neurotransmitter, in our brains. Neurons communicate via neurotransmitters, chemicals which pass from one nerve cell to another. A transporter molecule recycles unused transmitter and carries it back to the pre-synaptic cell. For serotonin, that shuttle is c...

Mar212016 by Pharmaceutical TechNo Comments

Weighing and Dispensing Process and Technology in Pharma Industries

Drug Development, Pharmaceutical Chemicals and Intermediates, Pharmaceutical Excipients and Drug Formulation, Pharmaceutical Instrumentation and Controls, Pharmaceutical Quality Assurance, Pharmaceutical Research and Development

Weighing and dispensing process in pharma industries occupies a high priority position. Over the last decades, increased regulations on the manufacturing processes in pharma manufacturing industries led the focus and result is the advanced technology and stringent policies and frameworks. The pharmaceutical companies can increase the speed and accuracy of their operations with weigh and dispense process technology. While, weighing and dispensing of solids and liquids is a very common activity throughout the pharmaceutical industry processes. Traditionally, workers dispense pharma materials by hand-scooping solids and pumping or pouring liquids. This is generally conducted in a warehouse during chemical production or in a pharmacy during pharmaceutical dosage-form manufacturing. The chanc...

Mar152016 by Pharmaceutical TechNo Comments

ICT an Aid to the Pharma Sector

Pharma Industry, Pharmacetiucal Infotech

Tremendous pressures exerted from every source for the societal and economic development keep exercising pressures from all around. Governments look forward for the companies from vivid industrial sectors to outperform and raise the scope for employment, GDP contribution and the revenues to the government in form to various taxes. At the same the companies are keen on huge investments in any state, only when the state is in a position of offer them good subsidies, and tax exemptions and infrastructure which can facilitate them with the logistics, human resource skill development, and the key issue of ICT facilitation. In today's scenario, many states are keen on encouraging the investments from pharma companies, and these locations have become a free zone for the companies of small and m...

Mar102016 by Pharmaceutical TechNo Comments

Global Pharma Industry trends

Pharma Industry, Pharmaceutical Business Development

Industry Experts have forecasted a 19 % growth for the Indian Pharmaceutical Industry for the year 2013. Morgan Stanley has said that Investments in research and trade mark expenditure will start bearing fruits in European Union and United States. Several new drugs are expected to be launched as a result of clinical trials and obtaining intellectual property rights. Apart from these, new emerging markets in Japan and other countries will have cascading positive effect in the pharmaceutical industries. Moody's have also forecast return of growth in 2013. They have also said that this status of the market will be stable for another one and half year paving the way for growth and earnings [Outlook report]. This is also based on the expected loss of patent protection of some of the high selli...

Mar52016 by Pharmaceutical TechNo Comments

Future of Pharma Industry – Biotechnology

BioPharma, Biotechnology, Pharma Industry, Pharmaceutical Business Development

Biotechnology can be defined as the use of living systems and organisms to develop or make useful products, or "any technological application that uses biological systems, living organisms or derivatives in order to make or modify products or processes for specific use. However, contrary to its name biotechnology is not a single technology. Rather it is a group of technologies that share two (common) characteristics; working with living cells and their molecules and having a wide range of practice uses that can improve our lives. Traditional biotechnology has been practiced since the beginning of records history. It has been used to enhance the agricultural production, to bake bread, brew alcoholic beverages, and breed food crops or domestic animals. Through early biotechnology, the ear...

Mar22016 by Pharmaceutical TechNo Comments

New challenges for The New Pharmaceutical Industry

Pharma Industry, Pharmaceutical Business Development

The pharmaceutical industry has entered in to a new era in the 21st century for extreme growth and innovations in technology. As there is a technological advancements exists, requirements and challenges are also persists. In pharmaceutical industry for this century, for the key players who are well established in market and intruders to the market have to be prepared to face important challenges and transformations from weak economy and certain financial bumps like price downs and scrutiny on business and ethical practices as well increase in regulation. Few of challenges are like: NCE is the new chemical entity which is most important factor for the pharmaceutical industry and is increasing rapidly with absence of ROI that is return on investment. Whilst, falling in the equity market ca...

Feb292016 by Pharmaceutical TechNo Comments

Hurdles to Global Pharma Markets Growth

Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Excipients and Drug Formulation

One of the premium industrial segments ever and one such industry on which many nations across the globe have relied upon for boosting the economic development is Pharma Industry. However, when we dwell in to the insights, this is one of the most regulated industries and of course it has to be, as it is directly related to the lives of many. The other factor which is tagged to the global pharma markets are the controversies involving the honchos of Pharma sector globally. There are numerous instances where few companies from pharma sector have been in news for one or the other controversies. One way or the other, the global pharma companies had always made news, be it the pricing mechanism, or the issue of handling patents, or the breach of regulations, one or the other issue always is o...